Skip to main content

Analysts Raise Price Target For UnitedHealth After Q2 Earnings Beat Expectations

Truist raised the target to $500 from $480 and with Buy rating unchanged following strong trends across the platform, a lower MLR, sizable free cash flow, and raised guidance.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.